查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609150

被忽视的热带疾病诊断市场：按服务、疾病、诊断方法、最终用途分类 - 全球预测 2025-2030

Neglected Tropical Diseases Diagnosis Market by Service (Centralized Service, POC Service), Disease (African Trypanosomiasis, Buruli Ulcer, Chagas Disease), Diagnostic Method, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年被忽视的热带疾病诊断市场规模为66.9亿美元，预计2024年将达到70.4亿美元，复合年增长率为5.80%，2030年将达到99.3亿美元，预计将达到1000万美元。

被忽视的热带疾病 (NTD) 包括影响超过 10 亿人的多种感染疾病，主要发生在热带和亚热带地区。被忽视的热带疾病是根据其对贫困人口的影响来定义的，是经济和社会发展的主要障碍。对 NTD 准确诊断的需求证明了这些疾病会导致慢性健康问题、使人衰弱的感染疾病和社会耻辱。其应用范围从基本诊断工具到先进的分子分析方法，对于疾病监测、有效的治疗计划和减少传播至关重要。最终使用领域包括医院、诊断实验室和研究机构，它们使用这些诊断来管理集体爆发、指导医疗政策和进行流行病学调查。 NTD 诊断的市场成长是由全球卫生资金的增加、意识的提高和诊断技术的技术进步所推动的。加强强调早期检测、准确诊断和具有成本效益的解决方案的官民合作关係和全球卫生措施正在为市场扩张提供机会。关键的成长要素包括政府和非政府投资的增加、分子和就地检验等诊断技术的创新以及受马苏病影响的地区获得医疗保健的机会的扩大。然而，市场挑战包括流行地区医疗基础设施不足、意识有限、监管障碍以及先进诊断工具的高成本。开发低成本、快速的 NTD 诊断测试存在机会，特别是那些可以在资源匮乏的环境中进行的测试。创新可以集中在可提供快速、准确结果的便携式整合诊断平台上，也可以透过用于资料传播和管理的数位健康技术来增强。为了利用这些商机，公司应专注于与政府和非政府组织的战略合作伙伴关係，投资于新诊断方法的研发，并致力于可扩展的生产技术。为了在这个市场实现永续成长，公司必须进行实质审查，以适应严格的法规环境并解决医疗保健服务的障碍。

主要市场统计
基准年[2023] 66.9亿美元
预计年份 [2024] 70.4亿美元
预测年份 [2030] 99.3亿美元
复合年增长率（%） 5.80%

市场动态：针对快速发展的被忽视的热带疾病诊断市场揭示的关键市场见解

被忽视的热带疾病诊断市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 解决被忽视的热带疾病的项目数量增加
    • 热带和亚热带国家被忽视的热带病患病率上升
    • 对疾病早期检测的需求不断增长
  • 市场限制因素
    • 欠低度开发国家缺乏对被忽视的热带疾病的治疗意识
  • 市场机会
    • 不断开发先进的被忽视热带疾病诊断设备
    • 活性化研究和开发，开发被忽视的热带疾病的创新诊断方法
  • 市场挑战
    • 缺乏标准化诊断工具

波特五力：驾驭被忽视的热带疾病诊断市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解被忽视的热带疾病诊断市场的外部影响

外部宏观环境因素在塑造被忽视的热带疾病诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解被忽视的热带疾病诊断市场的竞争格局

对被忽视的热带疾病诊断市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 在被忽视的热带疾病诊断市场中的定位矩阵供应商绩效评估

FPNV 定位矩阵是评估被忽视的热带疾病诊断市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了被忽视的热带疾病诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对被忽视的热带疾病诊断市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 解决被忽视的热带疾病的项目数量增加
      • 热带和亚热带国家经常被忽视的热带病患病率不断上升
      • 对疾病早期检测的需求不断增长
    • 抑制因素
      • 开发中国家缺乏对被忽视的热带疾病的治疗认识
    • 机会
      • 先进被忽视热带疾病诊断设备的开发进展
      • 加强研发力度，为被忽视的热带疾病开发创新诊断方法
    • 任务
      • 缺乏标准化诊断工具
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章被忽视的热带疾病诊断市场：依服务分类

  • 集中服务
  • 点对点服务

第七章被忽视的热带疾病诊断市场：依疾病分类

  • 非洲昏睡病
  • 布鲁里溃疡
  • 南美锥虫病
  • 基孔肯雅热
  • 登革热
  • 麦地那蠕虫病
  • 包虫病
  • 食物中毒细菌
  • 利什曼原虫症
  • 麻风
  • 淋巴丝虫病
  • 盘尾丝虫病
  • 狂犬病
  • 疥疮
  • 血吸虫病
  • 被蛇咬伤中毒
  • 土源性蠕虫感染疾病
  • 绦虫病/囊尾蚴病
  • 草莓瘤

第八章诊断方法被忽视的热带疾病诊断市场

  • 传统方法
  • 分子/现代方法

第九章被忽视的热带疾病诊断市场：依最终用途分类

  • 临床实验室
  • 家庭保健
  • 医院/诊所

第十章 美洲被忽视的热带疾病诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区被忽视的热带疾病诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲被忽视的热带疾病诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Coris BioConcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd
  • Genome Diagnostics Pvt. Ltd.
  • InBios International, Inc.
  • Omega Diagnostics Group PLC
  • Ortho Clinical Diagnostics
  • Oscar Medicare Pvt. Ltd.
  • Premier Medical Corporation Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix LLC
Product Code: MRR-742BD5181EB6

The Neglected Tropical Diseases Diagnosis Market was valued at USD 6.69 billion in 2023, expected to reach USD 7.04 billion in 2024, and is projected to grow at a CAGR of 5.80%, to USD 9.93 billion by 2030.

Neglected Tropical Diseases (NTDs) include a diverse array of infections affecting over a billion people primarily in tropical and subtropical regions. Defined by their impact on impoverished populations, they significantly hinder economic development and societal progression. The necessity of accurate NTD diagnosis underlies these diseases' ability to cause chronic health issues, debilitating infections, and societal stigma. Applications span from basic diagnostic tools to advanced molecular methodologies, crucial for disease surveillance, effective treatment planning, and transmission reduction. End-use sectors include hospitals, diagnostic laboratories, and research institutions, which utilize these diagnoses to manage outbreaks, guide healthcare policy, and conduct epidemiological studies. Market growth for NTD diagnoses is driven by increased global health funding, heightened awareness, and technological advancements in diagnostic techniques. A growing number of public-private partnerships and global health initiatives emphasize early detection, accurate diagnostics, and cost-effective solutions, presenting opportunities for market expansion. Key growth factors include increased governmental and non-governmental investments, innovation in diagnostic technologies like molecular and point-of-care testing, and expanding access to healthcare in regions burdened by NTDs. However, market challenges include inadequate healthcare infrastructure in endemic regions, limited awareness, regulatory barriers, and the high cost of advanced diagnostic tools. Opportunities exist in developing low-cost, rapid diagnostic tests for NTDs, particularly those deployable in low-resource settings. Innovation can focus on portable and integrated diagnostic platforms that provide quick and accurate results, potentially augmented by digital health technologies for data dissemination and management. To capitalize on these opportunities, companies should focus on strategic collaborations with governments and NGOs, invest in R&D for novel diagnostics, and work towards scalable production techniques. Due diligence must be executed in navigating stringent regulatory environments and addressing healthcare delivery barriers to sustainably grow within this market.

KEY MARKET STATISTICS
Base Year [2023] USD 6.69 billion
Estimated Year [2024] USD 7.04 billion
Forecast Year [2030] USD 9.93 billion
CAGR (%) 5.80%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neglected Tropical Diseases Diagnosis Market

The Neglected Tropical Diseases Diagnosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in number of programs to tackle neglected tropical diseases
    • Rising prevalence of neglected tropical diseases in tropical and subtropical countries
    • Growing demand for early disease identification
  • Market Restraints
    • Lack of neglected tropical diseases treatment awareness in underdeveloped countries
  • Market Opportunities
    • Growing development of advanced neglected tropical disease diagnosis devices
    • Rising R&D to develop innovative neglected tropical disease diagnosis
  • Market Challenges
    • Lack of standardization tools for diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Neglected Tropical Diseases Diagnosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neglected Tropical Diseases Diagnosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neglected Tropical Diseases Diagnosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neglected Tropical Diseases Diagnosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neglected Tropical Diseases Diagnosis Market

A detailed market share analysis in the Neglected Tropical Diseases Diagnosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neglected Tropical Diseases Diagnosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neglected Tropical Diseases Diagnosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neglected Tropical Diseases Diagnosis Market

A strategic analysis of the Neglected Tropical Diseases Diagnosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neglected Tropical Diseases Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., Coris BioConcept SPRL, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Genome Diagnostics Pvt. Ltd., InBios International, Inc., Omega Diagnostics Group PLC, Ortho Clinical Diagnostics, Oscar Medicare Pvt. Ltd., Premier Medical Corporation Ltd., Siemens AG, Thermo Fisher Scientific Inc., and ZeptoMetrix LLC.

Market Segmentation & Coverage

This research report categorizes the Neglected Tropical Diseases Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Centralized Service and POC Service.
  • Based on Disease, market is studied across African Trypanosomiasis, Buruli Ulcer, Chagas Disease, Chikungunya, Dengue, Dracunculiasis, Echinococcosis, Foodborne Trematodiases, Leishmaniasis, Leprosy, Lymphatic Filariasis, Onchocerciasis, Rabies, Scabies, Schistosomiasis, Snakebite Envenoming, Soil-transmitted Helminth Infections, Taeniasis/Cysticercosis, and Yaws.
  • Based on Diagnostic Method, market is studied across Conventional Method and Molecular/Modern Method.
  • Based on End-Use, market is studied across Clinical Labs, Home Healthcare, and Hospitals /Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in number of programs to tackle neglected tropical diseases
      • 5.1.1.2. Rising prevalence of neglected tropical diseases in tropical and subtropical countries
      • 5.1.1.3. Growing demand for early disease identification
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of neglected tropical diseases treatment awareness in underdeveloped countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development of advanced neglected tropical disease diagnosis devices
      • 5.1.3.2. Rising R&D to develop innovative neglected tropical disease diagnosis
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization tools for diagnosis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neglected Tropical Diseases Diagnosis Market, by Service

  • 6.1. Introduction
  • 6.2. Centralized Service
  • 6.3. POC Service

7. Neglected Tropical Diseases Diagnosis Market, by Disease

  • 7.1. Introduction
  • 7.2. African Trypanosomiasis
  • 7.3. Buruli Ulcer
  • 7.4. Chagas Disease
  • 7.5. Chikungunya
  • 7.6. Dengue
  • 7.7. Dracunculiasis
  • 7.8. Echinococcosis
  • 7.9. Foodborne Trematodiases
  • 7.10. Leishmaniasis
  • 7.11. Leprosy
  • 7.12. Lymphatic Filariasis
  • 7.13. Onchocerciasis
  • 7.14. Rabies
  • 7.15. Scabies
  • 7.16. Schistosomiasis
  • 7.17. Snakebite Envenoming
  • 7.18. Soil-transmitted Helminth Infections
  • 7.19. Taeniasis/Cysticercosis
  • 7.20. Yaws

8. Neglected Tropical Diseases Diagnosis Market, by Diagnostic Method

  • 8.1. Introduction
  • 8.2. Conventional Method
  • 8.3. Molecular/Modern Method

9. Neglected Tropical Diseases Diagnosis Market, by End-Use

  • 9.1. Introduction
  • 9.2. Clinical Labs
  • 9.3. Home Healthcare
  • 9.4. Hospitals /Clinics

10. Americas Neglected Tropical Diseases Diagnosis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Neglected Tropical Diseases Diagnosis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Neglected Tropical Diseases Diagnosis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Coris BioConcept SPRL
  • 4. DiaSys Diagnostic Systems GmbH
  • 5. F. Hoffmann-La Roche Ltd
  • 6. Genome Diagnostics Pvt. Ltd.
  • 7. InBios International, Inc.
  • 8. Omega Diagnostics Group PLC
  • 9. Ortho Clinical Diagnostics
  • 10. Oscar Medicare Pvt. Ltd.
  • 11. Premier Medical Corporation Ltd.
  • 12. Siemens AG
  • 13. Thermo Fisher Scientific Inc.
  • 14. ZeptoMetrix LLC

LIST OF FIGURES

  • FIGURE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CENTRALIZED SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POC SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY AFRICAN TRYPANOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BURULI ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHIKUNGUNYA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DRACUNCULIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ECHINOCOCCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY FOODBORNE TREMATODIASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEPROSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SNAKEBITE ENVENOMING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SOIL-TRANSMITTED HELMINTH INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TAENIASIS/CYSTICERCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY YAWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONVENTIONAL METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR/MODERN METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICAL LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS /CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 109. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 114. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 122. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 123. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 124. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 130. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 131. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 132. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 135. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 136. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 143. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 146. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 147. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 148. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 151. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 155. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 156. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 159. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 160. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 162. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 163. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 166. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 167. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 168. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 170. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 171. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 172. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 175. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 176. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 182. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 183. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 184. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 186. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 187. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 188. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 191. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 192. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 195. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 196. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 202. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 204. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 206. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023